Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly used to treat several types of tumors. Impact of this emerging therapy on patients’ health-related quality of life (HRQoL) is usually collected in clinical trials through standard questionnaires. However, this might not fully reflect H...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotté, François-Emery, Voillot, Paméla, Bennett, Bryan, Falissard, Bruno, Tzourio, Christophe, Foulquié, Pierre, Gaudin, Anne-Françoise, Lemasson, Hervé, Grumberg, Valentine, McDonald, Laura, Faviez, Carole, Schück, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519426/
https://www.ncbi.nlm.nih.gov/pubmed/32915159
http://dx.doi.org/10.2196/19694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519426/
https://www.ncbi.nlm.nih.gov/pubmed/32915159
http://dx.doi.org/10.2196/19694

Ejemplares similares